콘텐츠로 건너뛰기
Merck

주요 문서

모든 문서 보기

다음으로 건너뛰기

SML3705

Sigma-Aldrich

Olaparib

≥98% (HPLC)

동의어(들):

1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine, 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone, AZD-2281, KU-0059436

로그인조직 및 계약 가격 보기

About This Item

실험식(Hill 표기법):
C24H23FN4O3
CAS Number:
763113-22-0
Molecular Weight:
434.46
MDL number:
MFCD13185161
UNSPSC 코드:
12352200
NACRES:
NA.77
가격 및 재고 정보를 현재 이용할 수 없음
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의

Quality Level

100

분석

≥98% (HPLC)

양식

powder

색상

white to beige

solubility

DMSO: 2 mg/mL, clear (Warmed)

저장 온도

-10 to -25°C

SMILES string

Fc1c(cc(cc1)C=C4NNC(=O)c5c4cccc5)C(=O)N2CCN(CC2)C(=O)C3CC3

InChI

1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13-14,16,26H,6-7,9-12H2,(H,27,30)

InChI key

JQYIJKFTPJWNFM-UHFFFAOYSA-N

생화학적/생리학적 작용

Antineoplastic; Poly(ADP-ribose) polymerases-1 and 2 (PARP-1, PARP-2) inhibitor
Olaparib is an antineoplastic and potent inhibitor of poly(ADP-ribose) polymerases-1 and 2 (PARP-1, PARP-2) with an IC50 of 5 nM for PARP-1 and an IC50 of 1 nM for PARP-2. Olaparib is indicated to treat breast cancer, ovarian cancer, fallopian tube cancer, peritoneal cancer, pancreatic cancer, and prostate cancer.

픽토그램

Skull and crossbonesHealth hazard
GHS06,GHS08

신호어

Danger

유해 및 위험 성명서

H301,H360D

Hazard Classifications

Acute Tox. 3 Oral - Repr. 1B

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable

  • Specification Sheet

    • 가장 최신 버전 중 하나를 선택하세요:

    시험 성적서(COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our 문서 section.

    도움이 필요하시면 연락하세요. 고객 지원 부서

    이 제품을 이미 가지고 계십니까?

    문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

    문서 라이브러리 방문

    Zhong-Ze Fang et al.
    British journal of pharmacology, 167(6), 1271-1286 (2012-06-08)
    Noscapine is a promising anti-tumour agent. The purpose of the present study was to describe the metabolic map and investigate the bioactivation of noscapine. Ultra-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry-based metabolomics was used to analyse
    Pradeep K Naik et al.
    Journal of computer-aided molecular design, 25(5), 443-454 (2011-05-06)
    Noscapine and its derivatives are important microtubule-interfering agents shown to have potent anti-tumor activity. The binding free energies (ΔG (bind)) of noscapinoids computed using linear interaction energy (LIE) method with a surface generalized Born (SGB) continuum solvation model were in
    Aaron J DeBono et al.
    ChemMedChem, 7(12), 2122-2133 (2012-10-12)
    Noscapine is a phthalideisoquinoline alkaloid isolated from the opium poppy Papaver somniferum. It has long been used as an antitussive agent, but has more recently been found to possess microtubule-modulating properties and anticancer activity. Herein we report the synthesis and
    Thu-Thuy T Dang et al.
    Plant physiology, 159(2), 618-631 (2012-04-27)
    Noscapine is a benzylisoquinoline alkaloid produced in opium poppy (Papaver somniferum) and other members of the Papaveraceae. It has been used as a cough suppressant and more recently was shown to possess anticancer activity. However, the biosynthesis of noscapine in
    V Pannu et al.
    Cell death & disease, 3, e346-e346 (2012-07-13)
    Centrosome amplification (CA) and resultant chromosomal instability have long been associated with tumorigenesis. However, exacerbation of CA and relentless centrosome declustering engender robust spindle multipolarity (SM) during mitosis and may induce cell death. Recently, we demonstrated that a noscapinoid member
    모든 관련된 서류 보기

    자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

    고객지원팀으로 연락바랍니다.